Rituximab
August 6, 2024
Rituximab can be given in combination with many other medications to treat CLL or SLL.
Rituximab can be given in combination with many other medications to treat CLL or SLL.
Obinutuzumab can be given alone or in combination with many other medications to treat CLL or SLL.
A one page summary of what you need to know about the 3 most important tests that need to be done to guide your CLL treatment.
Measurable residual disease (MRD)-guided treatment of CLL with ibrutinib plus venetoclax significantly increased time in remission.
CLL is a leukemia, but what is leukemia? This article is a zooming out from CLL to help understand it in its broader context with other blood cancers.
In those over 80 with chronic lymphocytic leukemia (CLL), older age and not being treated with a novel agent frontline were associated with increased mortality. The leading cause of death in this group was the CLL itself.
By Phil Witt – CLL Patient About halfway between 59-60 years of age, I remarked to my wife, “I must be getting old.” I was having trouble balancing life as a
I’ve never really thought about putting this role to paper but come to think of it, this may be a very therapeutic exercise for me. So here goes.
Various combinations of venetoclax plus other agents such as venetoclax plus rituximab (RVe), venetoclax and obinutuzumab (GVe), or venetoclax plus rituximab plus obinutuzumab (GIVe) provide fixed duration treatment options with high rates of success.